Search results
Results from the WOW.Com Content Network
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, ... for $25 million cash and $150 million in stock. [28] ...
The stock of Alnylam Pharmaceuticals (NAS:ALNY, 30-year Financials) appears to be possible value trap, according to GuruFocus Value calculation.
In this article we will take a look at whether hedge funds think Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is a good investment right now. We check hedge fund and billionaire investor sentiment ...
Alnylam (ALNY) saw a big move last session, as its shares jumped nearly 11% on the day, amid huge volumes.
For premium support please call: 800-290-4726 more ways to reach us
Regulus was established in September 2007 by Alnylam Pharmaceuticals and Isis Pharmaceuticals. [1] microRNA explained
Alnylam (ALNY) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.